Cargando…

Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations

The tumor-stroma ratio (TSR) has been reported as a strong, independent prognostic parameter in colon cancer as well as in other epithelial cancer types, and may be implemented to routine pathology diagnostics. The TSR is an easy technique, based on routine hematoxylin and eosin stained histological...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Pelt, G. W., Kjær-Frifeldt, S., van Krieken, J. H. J. M., Al Dieri, R., Morreau, H., Tollenaar, R. A. E. M., Sørensen, F. B., Mesker, W. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182321/ https://www.ncbi.nlm.nih.gov/pubmed/30030621 http://dx.doi.org/10.1007/s00428-018-2408-z

Ejemplares similares

e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study
por: Smit, Marloes A, et al.
Publicado: (2021)

Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
por: Smit, Marloes A., et al.
Publicado: (2021)

Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment
por: Smit, Marloes A., et al.
Publicado: (2023)

Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
por: Sandberg, Tessa P., et al.
Publicado: (2018)

Erratum: Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
por: Sandberg, Tessa P., et al.
Publicado: (2019)

Standardization of the tumor-stroma ratio scoring method for breast cancer research
por: Hagenaars, Sophie C., et al.
Publicado: (2022)

Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study
por: Smit, Marloes, et al.
Publicado: (2019)

Tumor stroma as contributing factor in the lymph node metastases process?
por: Mesker, Wilma E., et al.
Publicado: (2019)

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer
por: Zunder, Stéphanie M., et al.
Publicado: (2018)

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer
por: Mesker, W E, et al.
Publicado: (2015)

The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
por: Kramer, C. J. H., et al.
Publicado: (2018)

Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
por: Eriksen, Ann C., et al.
Publicado: (2018)

Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma
por: Vangangelt, K. M. H., et al.
Publicado: (2017)

The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer
por: Ravensbergen, Cor J., et al.
Publicado: (2021)

Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study
por: Vogelaar, F. J., et al.
Publicado: (2016)

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
por: van Pelt, G.W., et al.
Publicado: (2019)

Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
por: Mesker, Wilma E., et al.
Publicado: (2009)

The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
por: Eriksen, Ann Christina, et al.
Publicado: (2018)

The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer
por: Vangangelt, Kiki M.H., et al.
Publicado: (2020)

The intra-tumoural stroma in patients with breast cancer increases with age
por: Vangangelt, Kiki M. H., et al.
Publicado: (2019)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
por: Ravensbergen, Cor J., et al.
Publicado: (2021)

The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage
por: Mesker, Wilma E., et al.
Publicado: (2007)

The role of artificial intelligence to quantify the tumour-stroma ratio for survival in colorectal cancer
por: Smit, Marloes A, et al.
Publicado: (2020)

Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer
por: Sandberg, Tessa P., et al.
Publicado: (2019)

Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer
por: Hagenaars, Sophie C., et al.
Publicado: (2021)

N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment
por: Boyaval, Fanny, et al.
Publicado: (2021)

Tumour‐stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case‐cohort study
por: Dang, Hao, et al.
Publicado: (2021)

Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohort
por: Hansen, T F, et al.
Publicado: (2014)

Characteristics of tumour stroma in regional lymph node metastases in colorectal cancer patients: a theoretical framework for future diagnostic imaging with FAPI PET/CT
por: Polack, Meaghan, et al.
Publicado: (2022)

Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients
por: van de Weerd, Simone, et al.
Publicado: (2022)

The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort
por: Hansen, Torben Frøstrup, et al.
Publicado: (2014)

Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures
por: Velstra, Berit, et al.
Publicado: (2012)

Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts
por: Hansen, Torben Frøstrup, et al.
Publicado: (2018)

Tumour-stroma ratio and prognosis in gastric adenocarcinoma
por: Kemi, Niko, et al.
Publicado: (2018)

Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study
por: Vogelaar, F Jeroen, et al.
Publicado: (2010)

The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study()
por: Eriksen, Ann C., et al.
Publicado: (2018)

Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer
por: Eriksen, Ann C., et al.
Publicado: (2017)

Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort
por: Eriksen, Ann C., et al.
Publicado: (2019)

The prognostic significance of tumour-stroma ratio in endometrial carcinoma
por: Panayiotou, Hannah, et al.
Publicado: (2015)

Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients
por: Speetjens, Frank M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_u31jekas066qv8c5r1ht42u6u9